The Drug Delivery to the Lungs Conference (DDL) is in it’s 36th year and attracts in excess of 1100 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by 117 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event. DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.
Program highlight: Making innovation happen, 11.12.2025
This interactive session explores the many faces of entrepreneurial success through two real-world case studies—one highlighting a university spin-out acquisition, the other a startup that concluded with valuable lessons and growth.
From Ideas to Products in Aerosol Drug Delivery (ADD): Barriers to Innovation, David A V Morton, Deakin University
Case study discussion
Topics that will be addressed:
– how innovation is defined, interpreted and valued
– the common pitfalls and challenges
– transitioning from a researcher to an entrepreneur: what now?
– how to turn an idea into a viable biotech product
Invited speakers:
- Anna-Dorothea Gorki, YGION Biomedical
- Jag Shur, Etheralis BioAI
- Charlotta Gummeson, Trustpoint Consulting AB